ResMed Income from Continuous Operations 2010-2025 | RMD
- ResMed income from continuous operations for the quarter ending June 30, 2025 was $0.380B, a 29.93% increase year-over-year.
- ResMed income from continuous operations for the twelve months ending June 30, 2025 was $1.401B, a 37.2% increase year-over-year.
- ResMed annual income from continuous operations for 2025 was $1.401B, a 37.2% increase from 2024.
- ResMed annual income from continuous operations for 2024 was $1.021B, a 13.75% increase from 2023.
- ResMed annual income from continuous operations for 2023 was $0.898B, a 15.15% increase from 2022.
ResMed Annual Income from Continuous Operations (Millions of US $) |
|
---|---|
2025 | $1,401 |
2024 | $1,021 |
2023 | $898 |
2022 | $779 |
2021 | $475 |
2020 | $622 |
2019 | $405 |
2018 | $316 |
2017 | $342 |
2016 | $352 |
2015 | $353 |
2014 | $345 |
2013 | $307 |
2012 | $255 |
2011 | $227 |
2010 | $190 |
2009 | $146 |
ResMed Quarterly Income from Continuous Operations (Millions of US $) |
|
---|---|
2025-06-30 | $380 |
2025-03-31 | $365 |
2024-12-31 | $345 |
2024-09-30 | $311 |
2024-06-30 | $292 |
2024-03-31 | $300 |
2023-12-31 | $209 |
2023-09-30 | $219 |
2023-06-30 | $230 |
2023-03-31 | $233 |
2022-12-31 | $225 |
2022-09-30 | $210 |
2022-06-30 | $195 |
2022-03-31 | $179 |
2021-12-31 | $202 |
2021-09-30 | $204 |
2021-06-30 | $195 |
2021-03-31 | $-78 |
2020-12-31 | $180 |
2020-09-30 | $178 |
2020-06-30 | $178 |
2020-03-31 | $163 |
2019-12-31 | $161 |
2019-09-30 | $120 |
2019-06-30 | $69 |
2019-03-31 | $105 |
2018-12-31 | $125 |
2018-09-30 | $106 |
2018-06-30 | $110 |
2018-03-31 | $110 |
2017-12-31 | $10 |
2017-09-30 | $86 |
2017-06-30 | $102 |
2017-03-31 | $88 |
2016-12-31 | $77 |
2016-09-30 | $76 |
2016-06-30 | $83 |
2016-03-31 | $91 |
2015-12-31 | $96 |
2015-09-30 | $83 |
2015-06-30 | $87 |
2015-03-31 | $91 |
2014-12-31 | $91 |
2014-09-30 | $83 |
2014-06-30 | $88 |
2014-03-31 | $90 |
2013-12-31 | $87 |
2013-09-30 | $81 |
2013-06-30 | $73 |
2013-03-31 | $85 |
2012-12-31 | $78 |
2012-09-30 | $71 |
2012-06-30 | $77 |
2012-03-31 | $65 |
2011-12-31 | $63 |
2011-09-30 | $51 |
2011-06-30 | $58 |
2011-03-31 | $53 |
2010-12-31 | $58 |
2010-09-30 | $57 |
2010-06-30 | $53 |
2010-03-31 | $49 |
2009-12-31 | $46 |
2009-09-30 | $42 |
2009-06-30 | $45 |
2009-03-31 | $39 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $41.881B | $5.146B |
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $228.435B | 26.79 |
Boston Scientific (BSX) | United States | $153.732B | 36.66 |
Stryker (SYK) | United States | $149.077B | 30.35 |
EssilorLuxottica (ESLOY) | France | $146.011B | 0.00 |
Medtronic (MDT) | Ireland | $115.234B | 16.26 |
Lonza Group Ag (LZAGY) | Switzerland | $48.493B | 0.00 |
Haleon (HLN) | United Kingdom | $43.717B | 24.97 |
Agilent Technologies (A) | United States | $34.119B | 22.24 |
GE HealthCare Technologies (GEHC) | United States | $33.772B | 15.87 |
Terumo (TRUMY) | Japan | $27.820B | 32.97 |
Koninklijke Philips (PHG) | Netherlands | $26.548B | 17.56 |
Insulet (PODD) | United States | $23.052B | 77.24 |
Zimmer Biomet Holdings (ZBH) | United States | $20.663B | 13.15 |
Smith & Nephew SNATS (SNN) | United Kingdom | $16.153B | 0.00 |
Baxter (BAX) | United States | $12.496B | 9.65 |
Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
Demant (WILYY) | Denmark | $8.121B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.804B | 28.67 |
Lantheus Holdings (LNTH) | United States | $3.750B | 10.14 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.442B | 24.08 |
Perrigo (PRGO) | Ireland | $3.247B | 8.11 |
Prestige Consumer Healthcare (PBH) | United States | $3.219B | 14.28 |
ICU Medical (ICUI) | United States | $3.055B | 20.80 |
Haemonetics (HAE) | United States | $2.616B | 11.68 |
LeMaitre Vascular (LMAT) | United States | $2.158B | 46.28 |
QuidelOrtho (QDEL) | United States | $1.816B | 11.43 |
AtriCure (ATRC) | United States | $1.781B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $1.676B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.566B | 67.25 |
Phibro Animal Health (PAHC) | United States | $1.291B | 16.50 |
AdaptHealth (AHCO) | United States | $1.279B | 18.17 |
Neogen (NEOG) | United States | $1.219B | 19.34 |
Acuren (TIC) | United States | $1.209B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.176B | 2454.00 |
Tilray Brands (TLRY) | Canada | $1.167B | 0.00 |
Valneva SE (VALN) | France | $0.975B | 0.00 |
InMode (INMD) | Israel | $0.896B | 8.29 |
Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
SNDL (SNDL) | Canada | $0.552B | 0.00 |
ZimVie (ZIMV) | United States | $0.534B | 20.60 |
Surmodics (SRDX) | United States | $0.534B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.506B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.501B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.468B | 16.10 |
Evolus (EOLS) | United States | $0.461B | 0.00 |
CeriBell (CBLL) | United States | $0.432B | 0.00 |
Owens & Minor (OMI) | United States | $0.414B | 3.67 |
Capricor Therapeutics (CAPR) | United States | $0.351B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.315B | 0.00 |
Canopy Growth (CGC) | Canada | $0.300B | 0.00 |
Omeros (OMER) | United States | $0.297B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
Brainsway (BWAY) | Israel | $0.273B | 55.65 |
Viemed Healthcare (VMD) | United States | $0.270B | 20.44 |
Aurora Cannabis (ACB) | Canada | $0.269B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.262B | 0.00 |
High Tide (HITI) | Canada | $0.248B | 0.00 |
Quanterix (QTRX) | United States | $0.234B | 0.00 |
Cerus (CERS) | United States | $0.228B | 0.00 |
Vireo Growth (VREOF) | United States | $0.217B | 0.00 |
Exagen (XGN) | United States | $0.212B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
Organigram Global (OGI) | Canada | $0.204B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.187B | 15.61 |
TriSalus Life Sciences (TLSI) | United States | $0.176B | 0.00 |
FitLife Brands (FTLF) | United States | $0.157B | 19.38 |
Biote (BTMD) | United States | $0.149B | 4.95 |
Jushi Holdings (JUSHF) | United States | $0.103B | 0.00 |
Jin Medical (ZJYL) | China | $0.095B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
MacroGenics (MGNX) | United States | $0.094B | 0.00 |
Fonar (FONR) | United States | $0.094B | 12.09 |
Oramed Pharmaceuticals (ORMP) | United States | $0.084B | 0.00 |
Apyx Medical (APYX) | United States | $0.075B | 0.00 |
Safety Shot (SHOT) | United States | $0.071B | 0.00 |
Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
Agape ATP (ATPC) | $0.064B | 0.00 | |
ImmuCell (ICCC) | United States | $0.053B | 31.05 |
Veru (VERU) | United States | $0.047B | 0.00 |
Zynex (ZYXI) | United States | $0.047B | 0.00 |
Nephros (NEPH) | United States | $0.044B | 34.42 |
Modular Medical (MODD) | United States | $0.039B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
United-Guardian (UG) | United States | $0.036B | 13.98 |
Trinity Biotech (TRIB) | Ireland | $0.025B | 0.00 |
Senestech (SNES) | United States | $0.023B | 0.00 |
INLIF (INLF) | $0.017B | 0.00 | |
Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Flora Growth (FLGC) | United States | $0.011B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
InterCure (INCR) | Israel | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |